SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Pandion Therapeutics Q3 EPS $(0.51), Sales $2.63M

Pandion Therapeutics (NASDAQ:PAND) reported quarterly losses of $(0.51) per share. The company reported $2.63 million in sales this quarter.

· 11/16/2020 16:04
Pandion Therapeutics (NASDAQ:PAND) reported quarterly losses of $(0.51) per share. The company reported $2.63 million in sales this quarter.